Clinical Trials Logo

Filter by:
NCT ID: NCT05777356 Completed - Clinical trials for Focus: Nutritional Deficiency

Sanitary Napkins for Urinary Assessment of Micronutrients

Start date: March 8, 2023
Phase:
Study type: Observational

This study aims to find an easy urinary collection method for the assessment of urinary markers of micronutrient status.

NCT ID: NCT05770973 Completed - Ptosis, Eyelid Clinical Trials

Effect of Eyelid Patching After Ptosis Surgery

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The goal of this randomized, controlled, observer-blinded study is to compare the effect of compression dressing after ptosis surgery. The main question it aims to answer are: Effect of dressing on edema, hematoma, scar formation, ocular surface irritation and postoperative pain. Patients are randomized after surgery for compression dressing or not. Results are scored by a blinded observer. type of study: clinical trial

NCT ID: NCT05768360 Completed - Clinical trials for Healthy Male Subjects

A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects

Start date: April 25, 2023
Phase: Phase 1
Study type: Interventional

This study will assess the effects of savolitinib on the pharmacokinetics (PK) of substrates of human transporters digoxin (P-gp), rosuvastatin (OATP1B1/3), metformin (OCT2, MATE1/2K), and furosemide (OAT1/3) in healthy male subjects, performed at a single clinical unit.

NCT ID: NCT05764265 Completed - Clinical trials for Pulmonary Arterial Hypertension

Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

Start date: March 27, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to measure the long-term safety and efficacy profile of LTP001 in participants with pulmonary arterial hypertension (PAH). The study offers participants who had completed the CLTP001A12201 double-blind parent study in PAH an opportunity to receive LTP001 (whether they were on LTP001 or not). Unblinding of the treatment received in CLTP001A12201 is generally not needed, but can occur on request by the investigator.

NCT ID: NCT05755646 Completed - Breast Cancer Clinical Trials

Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial

WIn-HFS
Start date: March 10, 2023
Phase: N/A
Study type: Interventional

The present pilot study investigates the feasibility of a prospective larger confirmatory study on the efficacy of Dr. Hauschka Med Ice Plant Intensive Cream for the prevention of hand-foot syndrome in patients with breast carcinoma undergoing therapy with doxorubicin and / or docetaxel.

NCT ID: NCT05749731 Completed - COVID-19 Clinical Trials

Pan-European Study on Geriatric Rehabilitation After COVID-19 Disease

EU-COGER
Start date: October 1, 2020
Phase:
Study type: Observational

Older and more vulnerable persons are more likely to get very ill when infected with the coronavirus, and have the highest COVID-19 morbidity and mortality rate. The majority of patients that are admitted to the hospital are older (>70 years), and some of them have been admitted to Intensive Care Units (ICU). In the case of rehabilitation of older patients post-COVID-19, we do not know what the course of recovery for these patients will be, and what treatment/approaches will deliver the best outcomes. Persons that are recovering from a COVID-19 infection, and admitted on a geriatric ward for early rehabilitation, or geriatric rehabilitation ward or facility, can be included in the study. They will receive routine, usual care; participation in this study will not affect their rehabilitation care. Routine care data will be collected from their electronic patient files at admission to geriatric rehabilitation, and at discharge. This also includes some data about their premorbid status. In addition, study participants will be called six weeks and six months after discharge from rehabilitation and asked some questions about their recovery. There is no risk association with participation in this study. Data will be anonymously collected in an online database. The primary aim of this study is to get insight into the course of recovery in (geriatric) rehabilitation patients affected by COVID-19 in Europe. Mainly, we are interested in functioning in activities of daily living (ADL-functioning) such as toileting, bathing, dressing, etc., and in quality of life. The second aim of this study is to get insight into the treatment modalities employed and the organization of geriatric rehabilitation that post-COVID patients in Europe receive. Therefore, we collect data on the types of care provided and the professionals involved. Moreover, we collect some patient characteristics such as year of birth, gender, date of admission and date of discharge; and data about complications such as delirium, pain, post-traumatic stress syndrome, hospital readmissions, and mortality. Our hypothesis is that most patients will show recovery during geriatric rehabilitation and in the six months after. However, we expect that the amount and/or speed of recovery will vary between patients.

NCT ID: NCT05747001 Completed - Epilepsy Clinical Trials

This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK

CENOR
Start date: January 27, 2023
Phase:
Study type: Observational

Cenobamate is a newly-FDA and EMA approved drug used to treat -focal-onset seizures in adult patients. The aim of the current study is to analyse retrospectively the overall effectiveness and tolerability of cenobamate from real-world data collected in patients who partecipated in the Early Access Program (EAP) and were treated with cenobamate as adjunctive ASM.

NCT ID: NCT05740410 Completed - Clinical trials for Deep Vein Thrombosis

Retrospective Analysis for the ClotTriever Catheter to Investigate Safety and Effectiveness in the Treatment of Acute and Subacute Iliofemoral Deep Vein Thrombosis (DVT)

Start date: April 12, 2021
Phase:
Study type: Observational

The aim of the study is to evaluate the safety and performance of the ClotTriever catheter in the treatment of patients with symptomatic iliofemoral deep vein thrombosis (DVT)

NCT ID: NCT05740371 Completed - Clinical trials for Unstable Angina (Troponin Negative)

Safety of Argatroban Infusion in Conduction Disturbances

SAICoDis
Start date: April 18, 2017
Phase: Phase 4
Study type: Interventional

To determine change of QTc interval during intravenous argatroban infusion in patients undergoing percutaneous coronary intervention (PCI)

NCT ID: NCT05737251 Completed - Mental Health Clinical Trials

Positive Emotions Training (PoET) as an Online Intervention to Improve Mental Health: a Feasibility Study

Start date: March 18, 2022
Phase: N/A
Study type: Interventional

Positive psychology interventions are known to have an impact on mental health as well as on a number of beneficial characteristics like optimism, gratitude and self-efficacy. The new developed Positive Emotions Training (PoET) is one of the first holistic training programs covering eleven positive psychology constructs. The goal of this study was to test PoET's feasibility in the general population and to assess possible effects on positive and negative mental health factors. Additionally, possible effects on optimism, gratitude, happiness, resilience, and self-efficacy were examined. Hypotheses: 1. It was hypothesized that participants receiving PoET would show a significant increase in positive mental health factors one month after the second training day. 2. It was expected to find a significant decrease in depression, anxiety, and stress symptoms one month after the second training day. 3. It was hypothesized that participants in a control group would not show any significant changes in this regard. Methods: The sample (n = 101) was allocated to PoET (n = 55) or control (n = 46) which did not receive any treatment. The allocation was neither randomized nor matched. Participants in the PoET group completed a whole of two training sessions (3.5 hours each) that were conducted in an online format (via Zoom) with groups of about 30 people. These sessions included the following positive psychology constructs: happiness, hope, humour, optimism, gratitude, self-efficacy, flow, meaningfulness, forgiveness, spirituality, resilience. All participants completed positive and negative mental health measures at the beginning of the first training session and at the beginning of the second one as well as 30 days after the second session. Additionally, they had to complete two short items regarding stress and mood after each training session. They were given an exercise booklet with descriptions and explanations for all exercises during the training and at home. The week between the two sessions was called "7-day-challenge" to motivate the participants to try out several exercises at home. Data was collected pseudonymised via Socisurvey. Data analysis was conducted with RStudio. Two-factorial repeated measures ANOVAs were conducted to test for possible effects of PoET on mental health.